secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mirion Technologies, Inc. (MIR)
CIK:        0001809987
Form:       8-K
Filed at:   2022-10-03T23:59:59+00:00
Accession:  0001628280-22-025820
Event type: leadership
Sentiment:  positive
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mirion appoints Michael Rossi as Medical Group President; he joins from Novartis
--------------------------------------------------------------------------------

- Michael Rossi appointed President of Mirion Medical, reporting to CEO Tom Logan.
- Rossi previously Head of Radioligand Imaging at Novartis' Advanced Accelerator Applications.
- Employment terms: base salary $470,000, target bonus 60% of base, initial RSUs valued at $650,000.
- CEO Tom Logan had been acting as Medical segment President; Rossi to drive organic/inorganic growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809987/000162828022025820/0001628280-22-025820-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809987/000162828022025820/mir-20221003.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-025820

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer